Compositions for oral administration of zoledronic acid or related compounds for treating disease
AssigneeAntecip Bioventures II LLC
InventorHerriot Tabuteau
Life of this patent
Estimating the term…
Abstract
Oral dosage forms of osteoclast inhibitors, such as zoledronic acid, in an acid or a salt form can be used to treat or alleviate pain or related conditions, such as arthritis.
Claims30
A method of treating arthritis comprising orally administering a zoledronic acid to a human being suffering from arthritis, wherein the zoledronic acid is in an acid form or a salt form, wherein the human being is fasted for at least 2 hours prior to receiving the zoledronic acid and the human being is fasted for at least 1 hour after receiving the zoledronic acid, wherein the zoledronic acid has a bioavailability that is 1.1% to about 4%, and wherein the human being experiences pain relief as a result of receiving the zoledronic acid.
A method of providing zoledronic acid to a human being comprising orally administering a zoledronic acid to a human being in need of treatment with zoledronic acid, wherein the zoledronic acid is in a salt form, wherein the human being is fasted for at least 2 hours prior to receiving the zoledronic acid and the human being is fasted for at least 1 hour after receiving the zoledronic acid, and wherein the zoledronic acid has a bioavailability that is 1.1% to about 4%.
Dependencies are inferred from the claim text.